4//SEC Filing
Currie Mark G 4
Accession 0001209191-22-033983
CIK 0001446847other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:06 PM ET
Size
8.8 KB
Accession
0001209191-22-033983
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2022-06-01+21,571→ 591,758 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001478244
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:06 PM ET
- Size
- 8.8 KB